Shoemaker CB - Search Results

1

Accelerated neuronal cell recovery from Botulinum neurotoxin intoxication by targeted ubiquitination.

Kuo CL, Oyler GA, Shoemaker CB. Kuo CL, et al. Among authors: shoemaker cb. PLoS One. 2011;6(5):e20352. doi: 10.1371/journal.pone.0020352. Epub 2011 May 24. PLoS One. 2011. PMID: 21629663 Free PMC article.

2

Identification and characterization of a novel cell-penetrating peptide.

Sheng J, Oyler G, Zhou B, Janda K, Shoemaker CB. Sheng J, et al. Among authors: shoemaker cb. Biochem Biophys Res Commun. 2009 May 1;382(2):236-40. doi: 10.1016/j.bbrc.2008.11.139. Epub 2008 Dec 11. Biochem Biophys Res Commun. 2009. PMID: 19084505 Free PMC article.

3

Lipid and cationic polymer based transduction of botulinum holotoxin, or toxin protease alone, extends the target cell range and improves the efficiency of intoxication.

Kuo CL, Oyler G, Shoemaker CB. Kuo CL, et al. Among authors: shoemaker cb. Toxicon. 2010 Feb-Mar;55(2-3):619-29. doi: 10.1016/j.toxicon.2009.10.019. Epub 2009 Oct 21. Toxicon. 2010. PMID: 19852976 Free PMC article.

4

Efficient serum clearance of botulinum neurotoxin achieved using a pool of small antitoxin binding agents.

Sepulveda J, Mukherjee J, Tzipori S, Simpson LL, Shoemaker CB. Sepulveda J, et al. Among authors: shoemaker cb. Infect Immun. 2010 Feb;78(2):756-63. doi: 10.1128/IAI.01084-09. Epub 2009 Nov 16. Infect Immun. 2010. PMID: 19917718 Free PMC article.

5

Camelid single domain antibodies (VHHs) as neuronal cell intrabody binding agents and inhibitors of Clostridium botulinum neurotoxin (BoNT) proteases.

Tremblay JM, Kuo CL, Abeijon C, Sepulveda J, Oyler G, Hu X, Jin MM, Shoemaker CB. Tremblay JM, et al. Among authors: shoemaker cb. Toxicon. 2010 Nov;56(6):990-8. doi: 10.1016/j.toxicon.2010.07.003. Epub 2010 Jul 14. Toxicon. 2010. PMID: 20637220 Free PMC article.

6

Targeting botulinum neurotoxin persistence by the ubiquitin-proteasome system.

Tsai YC, Maditz R, Kuo CL, Fishman PS, Shoemaker CB, Oyler GA, Weissman AM. Tsai YC, et al. Among authors: shoemaker cb. Proc Natl Acad Sci U S A. 2010 Sep 21;107(38):16554-9. doi: 10.1073/pnas.1008302107. Epub 2010 Sep 7. Proc Natl Acad Sci U S A. 2010. PMID: 20823219 Free PMC article.

7

Retargeting Clostridium difficile Toxin B to Neuronal Cells as a Potential Vehicle for Cytosolic Delivery of Therapeutic Biomolecules to Treat Botulism.

Krautz-Peterson G, Zhang Y, Chen K, Oyler GA, Feng H, Shoemaker CB. Krautz-Peterson G, et al. Among authors: shoemaker cb. J Toxicol. 2012;2012:760142. doi: 10.1155/2012/760142. Epub 2011 Sep 20. J Toxicol. 2012. PMID: 21941543 Free PMC article.

8

A novel strategy for development of recombinant antitoxin therapeutics tested in a mouse botulism model.

Mukherjee J, Tremblay JM, Leysath CE, Ofori K, Baldwin K, Feng X, Bedenice D, Webb RP, Wright PM, Smith LA, Tzipori S, Shoemaker CB. Mukherjee J, et al. Among authors: shoemaker cb. PLoS One. 2012;7(1):e29941. doi: 10.1371/journal.pone.0029941. Epub 2012 Jan 6. PLoS One. 2012. PMID: 22238680 Free PMC article.

9

Persistence of Botulinum neurotoxin inactivation of nerve function.

Shoemaker CB, Oyler GA. Shoemaker CB, et al. Curr Top Microbiol Immunol. 2013;364:179-96. doi: 10.1007/978-3-642-33570-9_9. Curr Top Microbiol Immunol. 2013. PMID: 23239354 Free PMC article.

10

Sheep monoclonal antibodies prevent systemic effects of botulinum neurotoxin A1.

Mukherjee J, McCann C, Ofori K, Hill J, Baldwin K, Shoemaker CB, Harrison P, Tzipori S. Mukherjee J, et al. Among authors: shoemaker cb. Toxins (Basel). 2012 Dec;4(12):1565-81. doi: 10.3390/toxins4121565. Toxins (Basel). 2012. PMID: 23342681 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters